Cortechs.ai | Cortechs.ai Expands Partnership with Strategic Radiology to Advance Imaging Innovation Across Private Practices

Cortechs.ai Expands Partnership with Strategic Radiology to Advance Imaging Innovation Across Private Practices

San Diego, CA – Cortechs.ai, a leading provider of AI-powered quantitative imaging solutions, is proud to announce the expansion of its partnership with Strategic Radiology, a coalition of 47 independent, radiologist-owned practices serving over 300 hospitals and 450 imaging centers across 30 states.  

Building on a longstanding collaboration around NeuroQuant, Cortechs.ai and Strategic Radiology have now broadened their alliance to include Cortechs.ai’s full suite of imaging solutions, including OnQ Prostate, NeuroQuant MS, NeuroQuant Brain Tumor, and more. 

“Strategic Radiology has always been a forward-thinking coalition, and we’re thrilled to deepen our relationship,” said Kyle Frye, CEO of Cortechs.ai. “By expanding our partnership beyond NeuroQuant, we’re empowering Strategic Radiology members with a full spectrum of imaging tools that support better diagnostics, improved outcomes, and more efficient care delivery. This is a strategic win for both organizations and for the patients we ultimately serve.” 

This expanded partnership offers preferred pricing incentives to Strategic Radiology member practices, enabling easier access to Cortechs.ai’s portfolio through Strategic Radiology’s group purchasing infrastructure. The collaboration is designed to accelerate adoption, standardize imaging workflows, and enhance clinical quality across Strategic Radiology’s national network. 

“Strategic Radiology is committed to advancing innovation that strengthens independent private practice and improves patient care,” said Scott Bundy, MD, FACR, CEO and Chair of the Board, Strategic Radiology. “Expanding our group purchasing agreement with Cortechs.ai gives our member practices more cost-effective access to proven AI solutions that enhance diagnostic accuracy, streamline workflows, and reinforce our coalition’s focus on clinical quality and physician-led care.” 

The renewed partnership aligns with Strategic Radiology’s mission to maintain autonomy while leveraging shared resources, proprietary analytics, and a unique Patient Safety Organization (PSO) focused on imaging quality. Cortechs.ai’s solutions complement these efforts by offering quantifiable insights that support consistency and clinical decision-making to deliver confident, data-driven care. 

About Cortechs.ai 

Cortechs.ai is a leader in AI applications in radiology. Cortechs.ai uses cutting-edge technologies in medical imaging to revolutionize disease screening and early detection so patients can enjoy longer, healthier lives. The company develops and markets breakthrough medical device software that quantifies and tracks neurodegenerative diseases and assists in the detection of clinically significant cancer. Cortechs.ai’s industry-leading brain imaging software provides radiologists, neurologists, oncologists, and clinical researchers worldwide with a convenient and cost-effective way to quantify brain structures for assessing Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma, and other brain abnormalities. The company has FDA-cleared products for use in helping the diagnosis and follow-up of neurodegenerative and traumatic brain conditions, as well as prostate cancer. Please visit www.cortechs.ai for further information and follow us on Twitter, LinkedIn, and Facebook. 

For more information, please contact: 

___________ 

info@cortechs.ai   

+1 858 459 9700 

About Strategic Radiology 

Strategic Radiology is a coalition of independent, privately owned radiology practices that collaborate to improve quality, share best practices, and maintain clinical autonomy. Representing over 2,200 radiologists nationwide, SR offers its members access to proprietary tools, executive forums, and a unique Patient Safety Organization dedicated to imaging excellence. 

More Resources

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

02/20/2026

NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging

FDA 510(k)-Pending NeuroQuant® PET delivers automated, standardized quantification for amyloid, tau, and FDG imaging in dementia care.

02/19/2026

How Cortechs.ai Protects ePHI: HIPAA‑Aligned Controls—and Beyond

Cortechs.ai’s HIPAA-aligned, defense-in-depth security safeguards ePHI across AI workflows—exceeding baseline compliance standards.

02/11/2026

NeuroQuant Normative Database: Advancing Age‑ and Sex‑Specific Brain Volumetry

Learn how the latest updates to the NeuroQuant normative database white paper strengthen age- and sex-specific brain volumetry and enhance clinical confidence.
Scroll to Top